These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 24119540)

  • 1. Epidermin and gallidermin: Staphylococcal lantibiotics.
    Götz F; Perconti S; Popella P; Werner R; Schlag M
    Int J Med Microbiol; 2014 Jan; 304(1):63-71. PubMed ID: 24119540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of aminovinyl-cysteine-containing peptides and its application in the production of potential drug candidates.
    Sit CS; Yoganathan S; Vederas JC
    Acc Chem Res; 2011 Apr; 44(4):261-8. PubMed ID: 21366289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circumventing the effect of product toxicity: development of a novel two-stage production process for the lantibiotic gallidermin.
    Valsesia G; Medaglia G; Held M; Minas W; Panke S
    Appl Environ Microbiol; 2007 Mar; 73(5):1635-45. PubMed ID: 17194841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.
    Escano J; Ravichandran A; Salamat B; Smith L
    Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.
    Bierbaum G; Götz F; Peschel A; Kupke T; van de Kamp M; Sahl HG
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):119-127. PubMed ID: 8775972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lantibiotic production is a burden for the producing staphylococci.
    Ebner P; Reichert S; Luqman A; Krismer B; Popella P; Götz F
    Sci Rep; 2018 May; 8(1):7471. PubMed ID: 29749386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranslationally modified bacteriocins--the lantibiotics.
    Guder A; Wiedemann I; Sahl HG
    Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual role of GdmH in producer immunity and secretion of the Staphylococcal lantibiotics gallidermin and epidermin.
    Hille M; Kies S; Götz F; Peschel A
    Appl Environ Microbiol; 2001 Mar; 67(3):1380-3. PubMed ID: 11229936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of genetically engineered gallidermin and epidermin analogs.
    Ottenwälder B; Kupke T; Brecht S; Gnau V; Metzger J; Jung G; Götz F
    Appl Environ Microbiol; 1995 Nov; 61(11):3894-903. PubMed ID: 8526502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of the lantibiotics epidermin and gallidermin: sequence analysis of the genes gdmT and gdmH, their influence on epidermin production and their regulation by EpiQ.
    Peschel A; Schnell N; Hille M; Entian KD; Götz F
    Mol Gen Genet; 1997 Apr; 254(3):312-8. PubMed ID: 9150266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lantibiotics, class I bacteriocins from the genus Bacillus.
    Lee H; Kim HY
    J Microbiol Biotechnol; 2011 Mar; 21(3):229-35. PubMed ID: 21464591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
    Bonelli RR; Schneider T; Sahl HG; Wiedemann I
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1449-57. PubMed ID: 16569864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multipronged approach for engineering novel peptide analogues of existing lantibiotics.
    Escano J; Smith L
    Expert Opin Drug Discov; 2015; 10(8):857-70. PubMed ID: 26004576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lantibiotic gallidermin acts bactericidal against Staphylococcus epidermidis and Staphylococcus aureus and antagonizes the bacteria-induced proinflammatory responses in dermal fibroblasts.
    Bengtsson T; Lönn J; Khalaf H; Palm E
    Microbiologyopen; 2018 Dec; 7(6):e00606. PubMed ID: 29536668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of ribosomal and non-ribosomal antimicrobial peptides produced by Gram positive bacteria.
    Tajbakhsh M; Karimi A; Fallah F; Akhavan MM
    Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):20-32. PubMed ID: 29096754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic.
    Schnell N; Entian KD; Götz F; Hörner T; Kellner R; Jung G
    FEMS Microbiol Lett; 1989 Apr; 49(2-3):263-7. PubMed ID: 2765032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lantibiotics].
    Israil A
    Bacteriol Virusol Parazitol Epidemiol; 1992; 37(3-4):1-8. PubMed ID: 1340251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on the fermentative production of lantibiotics by staphylococci.
    Hörner T; Ungermann V; Zähner H; Fiedler HP; Utz R; Kellner R; Jung G
    Appl Microbiol Biotechnol; 1990 Feb; 32(5):511-7. PubMed ID: 1366437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallidermin: a new lanthionine-containing polypeptide antibiotic.
    Kellner R; Jung G; Hörner T; Zähner H; Schnell N; Entian KD; Götz F
    Eur J Biochem; 1988 Oct; 177(1):53-9. PubMed ID: 3181159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lantibiotics: insight and foresight for new paradigm.
    Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.